In recent years, new issues related to quality
assurance for pharmaceutical products have
arisen. These issues have generally resulted
from the progressive globalization of the
pharmaceutical industry. Supply chains
have been growing wider in scope. Data
integrity deficiencies have ballooned around
the world, resulting in US and European
regulatory guidances. And the introduction
of technical innovations, such as continuous
manufacturing, has made new approaches to
manufacturing and quality control a necessity. In light of these circumstances, PDA’s
Japan Chapter hosted its 23rd annual meeting with the theme: “New
Trends in Quality
Assurance,” Nov. 29–30, in
Tokyo.